KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Other financing activities: 2013-2014

Historic Other financing activities for Xenon Pharmaceuticals (XENE) over the last 2 years, with Dec 2014 value amounting to $1.5 million.

  • Xenon Pharmaceuticals' Other financing activities rose 776.92% to $228,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2014, which is 44.03% down from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Other financing activities of $1.5 million as of FY2014, which was down 44.03% from $2.7 million recorded in FY2013.
  • Xenon Pharmaceuticals' 5-year Other financing activities high stood at $2.7 million for FY2013, and its period low was $1.5 million during FY2014.
  • Its 2-year average for Other financing activities is $2.1 million, with a median of $2.1 million in 2013.
  • Data for Xenon Pharmaceuticals' Other financing activities shows a maximum YoY tumbled of 44.03% (in 2014) over the last 5 years.
  • Over the past 2 years, Xenon Pharmaceuticals' Other financing activities (Yearly) stood at $2.7 million in 2013, then crashed by 44.03% to $1.5 million in 2014.